Perspectives and Insights Into Phenylketonuria: Patient Narratives About the Early Years Following Newborn Screening

Newborn screening for Phenylketonuria (PKU) began in 1963, and since then knowledge and treatment recommendations have evolved. In the decades following newborn screening for PKU, individual and family experiences varied widely. We present narratives by people living with PKU during these years, including individuals actively following in PKU clinic and those who have been out of PKU clinic for many years. These stories describe different individual experiences, including diet discontinuation in childhood, changing treatment guidelines, and new treatments that have become available.

Authors

Institutions

Publication Details

Journal
American Journal of Medical Genetics Part C Seminars in Medical Genetics
Published
2024-09-17
DOI
https://doi.org/10.1002/ajmg.c.32110
Primary Topic
Metabolism and Genetic Disorders
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Perspectives and Insights Into Phenylketonuria: Patient Narratives About the Early Years Following Newborn Screening

Suzanne Hollander, B. Holmes, Stephanie Sacharow
American Journal of Medical Genetics Part C Seminars in Medical Genetics
Metabolism and Genetic Disorders
article

Perspectives and Insights Into Phenylketonuria: Patient Narratives About the Early Years Following Newborn Screening

Suzanne Hollander, B. Holmes, Stephanie Sacharow
article en

Abstract

Newborn screening for Phenylketonuria (PKU) began in 1963, and since then knowledge and treatment recommendations have evolved. In the decades following newborn screening for PKU, individual and family experiences varied widely. We present narratives by people living with PKU during these years, including individuals actively following in PKU clinic and those who have been out of PKU clinic for many years. These stories describe different individual experiences, including diet discontinuation in childhood, changing treatment guidelines, and new treatments that have become available.

American Journal of Medical Genetics Part C Seminars in Medical GeneticsVol. 196(2-3)
Boston Children's Hospital (US), Harvard University (US)
Rare Diseases Clinical Research Network, National Institutes of Health, National Institute of Neurological Disorders and Stroke, National Institute of Child Health and Human Development, National Center for Advancing Translational Sciences, Eunice Kennedy Shriver National Institute of Child Health and Human Development
Good health and well-being
Openalex Percentile: Top 77%
Metabolism and Genetic Disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Perspectives and Insights Into Phenylketonuria: Patient Narratives About the Early Years Following Newborn Screening — Suzanne Hollander, B. Holmes, et al. · American Journal of Medical Genetics Part C Seminars in Medical Genetics (2024) | TGRS Research Map | TGRS